Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease hepatocellular carcinoma
Phenotype |liver cirrhosis
Sentences 69
PubMedID- 23691139 This appears to happen during hepatocellular carcinoma (hcc) development in patients with liver cirrhosis, however, the accompanying transcriptional changes are virtually unknown.
PubMedID- 26331402 Is there a survival benefit in interventional radiology for hepatocellular carcinoma in patients with child-pugh c liver cirrhosis.
PubMedID- 23320019 Same observations have been reported after sorafenib treatment in mouse tumor models and in the peripheral blood of mrcc patients and hepatocellular carcinoma patients with liver cirrhosis [40–44].
PubMedID- 22254115 Chronic ethanol consumption causes changes in the liver, including fatty liver, inflammation and cirrhosis [179], and is an established risk factor for the development of hepatocellular carcinoma in patients with liver cirrhosis [180].
PubMedID- 22606287 Ald-associated disorders include fatty liver, inflammation, and hepatocellular carcinoma in patients with liver cirrhosis [41].
PubMedID- 20857114 Purpose: we have previously shown that continuous intra-arterial combination chemotherapy (iacc) might be more effective for advanced hepatocellular carcinoma (ahcc) in patients with hcv-related liver cirrhosis (c-lc) or alcoholic liver cirrhosis (a-lc) than in patients with hbv-related lc (b-lc).
PubMedID- 25903707 Perfusion computed tomography for detection of hepatocellular carcinoma in patients with liver cirrhosis.
PubMedID- 21318009 Moreover, chronic alcohol consumption is an established risk factor for the development of hepatocellular carcinoma in patients with liver cirrhosis [110].
PubMedID- 21210013 Aim: the ultrasonographic (us) detection of hepatocellular carcinoma (hcc) in patients with liver cirrhosis is based on the visualization of focal lesions.
PubMedID- 22523693 These pleiotropic and highly variable functions go some way towards explaining the miscellany of associations that have been detected for vdr polymorphisms, among others with the occurrence of hepatocellular carcinoma (hcc) in patients with liver cirrhosis, particularly in patients with an alcoholic etiology [30].
PubMedID- 22686857 Guidelines on nutritional management in japanese patients with liver cirrhosis from the perspective of preventing hepatocellular carcinoma.
PubMedID- 24223226 Furthermore, bcaa supplementation has been suggested to prevent the incidence of hepatocellular carcinoma in patients with liver cirrhosis [5]–[7].
PubMedID- 24746085 Objective: to explore the surveillance and diagnostic values of ultrasound (us), computed tomography (ct) and magnetic resonance imaging (mri) follow-ups in malignant transformation of cirrhotic nodules so as to improve the diagnostic accuracy of early hepatocellular carcinoma (hcc) with liver cirrhosis.
PubMedID- 22666283 Sorafenib prevents escape from host immunity in liver cirrhosis patients with advanced hepatocellular carcinoma.
PubMedID- 24949326 We recently experienced a case of ldlt for hepatocellular carcinoma combined with liver cirrhosis secondary to hepatitis b virus and hepatitis c virus infection.
PubMedID- 25009403 Aim: to review the currently available literature comparing laparoscopic to open resection of hepatocellular carcinoma (hcc) in patients with known liver cirrhosis.
PubMedID- 25513088 As hepatocellular carcinoma is often associated with liver cirrhosis, patients are at risk for postoperative liver failure.
PubMedID- 22504244 We describe a well-differentiated hepatocellular carcinoma (hcc) with alcohol-related liver cirrhosis in a 69-year-old man.
PubMedID- 24760057 Biochemical nutritional profile of liver cirrhosis patients with hepatocellular carcinoma.
PubMedID- 26116049 Risk factors for incisional hernia after hepatic resection for hepatocellular carcinoma in patients with liver cirrhosis.
PubMedID- 26444667 Negative impact of low body mass index on liver cirrhosis patients with hepatocellular carcinoma.
PubMedID- 22776279 Pure laparoscopic hepatectomy for hepatocellular carcinoma patients with severe liver cirrhosis.
PubMedID- 25574115 Twaij and colleagues have carried out a meta-analysis of cohort studies to review the currently available literature comparing laparoscopic to open resection of hepatocellular carcinoma in patients with known liver cirrhosis.
PubMedID- 19701751 Beneficial effect of metronomic chemotherapy on tumor suppression and survival in a rat model of hepatocellular carcinoma with liver cirrhosis.
PubMedID- 22882828 Characterizing the metabolic changes pertaining to hepatocellular carcinoma (hcc) in patients with liver cirrhosis is believed to contribute towards early detection, treatment, and understanding of the molecular mechanisms of hcc.
PubMedID- 25963079 Methods: using seldi-tof ms, serum protein/peptide profiles on the cm10 proteinchip arrays were obtained from a training group including 26 hbv-associated hepatocellular carcinoma patients with liver cirrhosis (lc), 30 hbv-associated lc patients, 85 patients at different stages of liver fibrosis, and 30 asymptomatic hbv carriers.
PubMedID- 25841913 Management of liver cirrhosis in patients with hepatocellular carcinoma.
PubMedID- 24403915 The exclusion criteria were as follows: positive results for hepatitis b surface antigen and antibody to human immunodeficiency virus type-1 (hiv-1), other liver diseases, including autoimmune hepatitis, primary biliary cirrhosis and alcoholic liver disease, liver cirrhosis, current development of hepatocellular carcinoma, severe renal dysfunction, abnormal thyroid function, abnormal parathyroid function, hypercalcemia, poorly controlled diabetes and hypertension, medication with chinese herbal medicine, history of interstitial pneumonia, severe depression, and allergy to peg-ifn, ribavirin, alfacalcidol.
PubMedID- 25702281 Serum paraoxonase 1 (pon1) is highly fucosylated in hepatocellular carcinoma (hcc) compared with liver cirrhosis (lc).
PubMedID- 20012230 Methods: in this study, we enrolled 20 patients having liver cirrhosis with hepatocellular carcinoma and randomly assigned them into two groups to receive autologous stem cells or placebo.
PubMedID- 19345541 Percutaneous laser ablation of hepatocellular carcinoma in patients with liver cirrhosis awaiting liver transplantation.
PubMedID- 23078008 Presence of k8 variants does not predispose to development of hepatocellular carcinoma in subjects with alcoholic liver cirrhosis.
PubMedID- 23392977 Impact of laparoscopic liver resection for hepatocellular carcinoma with f4-liver cirrhosis.
PubMedID- 26203823 An orthotopic mouse model of hepatocellular carcinoma with underlying liver cirrhosis.
PubMedID- 23118578 The transcatheter arterial chemoembolization (tace) method has been widely used for the management of unresectable, advanced hepatocellular carcinoma (hcc) in patients with compensated liver cirrhosis (1).
PubMedID- 22483505 The patient was a 62-year-old man, who suffered decompensated liver cirrhosis with hepatocellular carcinoma.
PubMedID- 23126044 hepatocellular carcinoma mostly develops in patients with liver cirrhosis due to chronic hepatitis c virus (hcv) infection.
PubMedID- 25091611 hepatocellular carcinoma (hcc)-closely associated with liver cirrhosis and, in fact, the main cause of death in patients with such disease-is now recognized as one of the most-prevalent and lethal neoplasms worldwide.
PubMedID- 23958083 Background & aims: liver transplantation (lt) is a promising treatment for patients with liver cirrhosis associated with hepatocellular carcinoma (hcc).
PubMedID- 24229043 A 69-year-old woman, who underwent cadaveric liver transplantation for non-b, non-c liver cirrhosis with hepatocellular carcinoma in april 2009, was admitted to our hospital because of graft dysfunction.
PubMedID- 22028976 In hepatocellular carcinoma, all patients with liver cirrhosis or chronic hepatitis b virus infection are at risk.
PubMedID- 25138286 Purpose: the aim of this retrospective cohort study was to clarify the effect of a branched-chain amino acids (bcaa) on the liver function and the prognosis of child-pugh class (c-p) a and b liver cirrhosis (lc) patients with advanced hepatocellular carcinoma (ahcc) undergoing hepatic arterial infusion chemotherapy (haic).
PubMedID- 24223741 Branched-chain amino acids ameliorate fibrosis and suppress tumor growth in a rat model of hepatocellular carcinoma with liver cirrhosis.
PubMedID- 23769079 The most common primary diseases was hepatitis b virus-related liver cirrhosis with or without hepatocellular carcinoma (64.3%).
PubMedID- 20304209 The best treatment for hepatocellular carcinoma (hcc) associated with liver cirrhosis is liver transplantation and the best results are obtained when the tumors fulfill the milan criteria.
PubMedID- 25436303 As hepatocellular carcinoma is often associated with liver cirrhosis, patients are at risk for postoperative liver failure.
PubMedID- 25465278 It remains to be determined to what extent hcv clearance will alter liver function and the risk for hepatocellular carcinoma in patients with liver cirrhosis.
PubMedID- 23690654 These findings precluded the patient from resectional surgery on the basis of bilateral hepatocellular carcinoma with extensive liver cirrhosis.
PubMedID- 20372847 Identification of beta2-microgloblin as a candidate for early diagnosis of imaging-invisible hepatocellular carcinoma in patient with liver cirrhosis.
PubMedID- 21528069 Intraductal papillary neoplasm of the bile duct in liver cirrhosis with hepatocellular carcinoma.

Page: 1 2